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Previous studies using an antibody to cis-urocanic
acid and mast-cell-depleted mice implicated both
cis-urocanic acid and mast cells in the mechanisms
by which ultraviolet B light suppresses systemic con-
tact hypersensitivity responses in mice. In the
absence of a direct stimulatory effect of cis-urocanic
acid on connective tissue mast cells, an indirect asso-
ciation was investigated. A blister induced in the rat
hind footpad was used to examine the effects of
slowly perfused cis-urocanic acid on cutaneous blood
¯ow. cis-Urocanic acid but not trans-urocanic acid
increased microvascular ¯ow by a mechanism largely
dependent on the combined activity of the neuro-
peptides, substance P and calcitonin gene-related
peptide. Perfusion of cis-urocanic acid over the base
of blisters induced in sensory-neuropeptide-depleted
rats did not have any stimulatory effect above that
seen with perfusion of cis-urocanic acid together
with neuropeptide receptor antagonists in control
rats. There was a small direct effect of cis-urocanic
acid on microvascular blood ¯ow. As both substance
P and calcitonin gene-related peptide could directly
degranulate connective tissue mast cells, this study
suggests that cis-urocanic acid indirectly activates
mast cells via its effects on peripheral terminals of
unmyelinated primary afferent sensory nerves. cis-
Urocanic-acid-induced neuropeptides may also con-
tribute to ultraviolet-B-induced cutaneous in¯amma-
tion and alterations to Langerhans cell activity. Key
words: histamine/mast cells/rodent/skin. J Invest Dermatol
117:886±891, 2001
U
ltraviolet radiation of wavelength 280±320 nm
(UVB) not only causes skin erythema and edema,
but is also carcinogenic and immunoregulatory
(Daynes et al, 1981; Kripke, 1981). There have
been de®nitive studies in rodents showing that UV-
induced tumors progress because of the adverse effects of UV
radiation on immunocompetency (Daynes et al, 1981; Kripke,
1981). Over the past two decades, the photoreceptors in skin for
UVB have been investigated and the mechanisms of this
immunoregulation have been studied in rodents and, more
recently, humans (Streilein et al, 1994; Beissert and Schwarz,
1999; Duthie et al, 1999). Very little UVB penetrates skin lower
than the epidermis. UV-initiated responses in the epidermis that
have been implicated in the mechanisms of immunomodulation
include cellular DNA damage, membrane oxidation, or altered
intracellular signaling leading to altered function or production of
immunosuppressive molecules (Applegate et al, 1989; Schwarz,
1998). Another important process induced by UVB is the
isomerization of trans-urocanic acid (UCA) to its cis isomer
(Noonan and De Fabo, 1992). trans-UCA (deaminated histidine)
is a molecular species located super®cially in the stratum corneum
of skin. On irradiation it is converted to the more soluble cis
isomer. The action spectrum of UVB-induced suppression of
contact hypersensitivity (CHS) responses in mice closely follows
the absorption spectrum of UCA (De Fabo and Noonan, 1983),
and mice genetically de®cient in histidase, and thus in skin UCA,
are not susceptible to immunosuppression by UVB irradiation
(Noonan and De Fabo, 1992).
The role of cis-UCA in UVB immunomodulation may vary
with the response examined and the experimental model
adopted. An antibody to cis-UCA neutralizes the immunosup-
pressive effects of UVB in many experimental models; in
particular UVB can suppress delayed type hypersensitivity
responses to viral or allogeneic antigens (El-Ghorr and
Norval, 1995; Moodycliffe et al, 1996) and CHS responses to
experimental haptens (Kondo et al, 1995). In our studies of
systemic CHS responses to trinitrochlorobenzene (TNCB) in
mice, a single intraperitoneal injection of 0.1 mg cis-UCA
antibody 4 h before UVB irradiation removed approximately
60% of the immunosuppression caused by 2 kJ per m2 UVB in
C57BL/6 mice and 12 kJ per m2 UVB in BALB/c mice (Hart
et al, 1997). Under these same experimental conditions, the
effect of cis-UCA (20 mg per mouse) was negated by approxi-
mately 60% (Hart et al, 1997).
In vitro effects of cis-UCA have been described on puri®ed
keratinocytes (Mitra et al, 1993; Jaksic et al, 1995; Norval et al,
1995), Langerhans cells (Beissert et al, 1997), ®broblasts (Bouscarel
et al, 1997), T lymphocytes (Holan et al, 1998), natural killer cells
(Gilmour et al, 1993), and monocytes (Hart et al, 1993). The
receptor for cis-UCA was ®rst hypothesized to be a histamine
receptor but, after different effects of these two molecules were
described on monocytes (Hart et al, 1993), keratinocytes (Jaksic et al,
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1995), and ®broblasts (Bouscarel et al, 1997), this theory was
discounted.
Recently we noted that dermal mast cells are critical to the initial
mechanisms by which cis-UCA suppresses a ``systemic'' CHS
response in mice (Hart et al, 1999). Mast-cell-depleted mice were
not responsive to UVB or cis-UCA for immunomodulation unless
they were reconstituted at the irradiated/injection site with
cultured bone-marrow-derived mast cell precursors from mast-
cell-replete mice (Hart et al, 1998a, 1999). We have also shown that
humans with basal cell carcinomas have a higher dermal mast cell
prevalence in sun-nonexposed skin, which supports the concept
that mast cells are critical to UVB-induced systemic immunosup-
pression and further that UVB-induced immunosuppression is
essential for skin cancer development (Grimbaldeston et al, 2000).
Thus, in our studies of UVB immunomodulation in mice, both
cis-UCA and mast cells were implicated (Hart et al, 1997, 1999).
Mast cells were also implicated in the studies of Streilein and
colleagues of UVB suppression of ``local'' CHS responses when the
sensitizing antigen was applied within 30 min to the irradiated site
(Niizeki et al, 1997; Alard et al, 1999). A further study had
concluded that cis-UCA stimulated mast cell degranulation, but in
that study human skin organ cultures, not puri®ed mast cells, had
been used (Wille et al, 1999). In this study we investigated whether
cis-UCA could activate mast cells directly or indirectly via
activation of sensory nerve terminals. Sensory-neuropeptide-
depleted rats and neuropeptide receptor antagonists were used to
investigate the latter possibility.
MATERIALS AND METHODS
Animals For studies of microvascular ¯ow and peritoneal mast cell
isolation, outbred male Sprague-Dawley rats (3 mo of age) were used.
Anesthesia was induced with sodium pentobarbitone (60 mg per kg,
intraperitoneally) and maintained by supplementary injections. Body
temperature was maintained at 37°C. Animals were sacri®ced by
barbiturate overdose at the completion of experiments.
Female BALB/c mice (4±8 wk of age) were obtained from the
Animal Resource Center of the South Australian Department of
Agriculture. All experiments were performed according to the ethical
guidelines of the National Health and Medical Research Council of
Australia.
UCA and UV irradiation The trans isomer of UCA was purchased
from Sigma (St. Louis, MO) and UV irradiated using a bank of FS40
sunlamps (Westinghouse, Pittsburgh, PA) emitting a broad band of UV,
250±360 nm, with 65% of the output in the UVB range (280±320 nm).
cis-UCA was puri®ed from irradiated trans-UCA by ion-exchange
chromatography (Hart et al, 1993). Both UCA isomers (200 mg per
mouse dissolved in 200 ml phosphate-buffered saline) were injected
subcutaneously into the upper backs of mice. Using the same bank of
FS40 sunlamps, mice were irradiated on clean-shaven 8 cm2 dorsal skin
as previously described using a PVC plastic ®lm to screen out
wavelengths less than 290 nm (Jaksic et al, 1995; Hart et al, 1998a; 1999).
The ears of the mice were protected with black adhesive insulation tape
and the mice were irradiated in individual compartments of Perspex
cages. The sunlamps were held 20 cm above the cages.
Isolation of rat peritoneal mast cells Rat peritoneal cells were
obtained by lavage with Tyrodes buffer with 0.1% gelatin (pH 6.7).
Washouts were centrifuged at 150 3 g for 10 min, and cell pellets were
resuspended in the same buffer and layered upon 22% metrizamide
(Sigma) gradients. Gradients were centrifuged at 280 3 g for 15 min; cell
pellets were washed and layered on a second 22% metrizamide gradient.
After centrifugation at 25 3 g for 20 min, the gradients were harvested
with the bottom third containing 99% pure mast cells as judged by their
size and granular content. These cells were mature connective tissue mast
cells as judged by their red color after staining with alcian blue-safranin
(Csaba's mast cell stain) (Hart et al, 1998a).
Quanti®cation of histamine release The histamine released from rat
peritoneal mast cells in response to mediators was determined by
¯uorometric analysis as previously described (Skov et al, 1985). Brie¯y,
2000 cells in a ®nal volume of 200 ml Tyrodes buffer with 0.1% gelatin
were incubated with mediators for 15 min in a 37°C water bath. The
mediators dissolved in Tyrodes buffer with 0.1% gelatin included
substance P (1±100 mM, Sigma), calcitonin gene-related peptide1±37
(CGRP1-37; 0.1±50 mM, CGRP, Peninsula Laboratories Europe, St.
Helens, Merseyside, U.K.), and 48/80 (1±10 mg per ml, Sigma).
Reactions were terminated by centrifugation at 300 3 g, 4°C for 5 min
and 25 ml supernatant aliquots were added to glass micro®bre-coated 96-
well assay plates for analysis (Skov et al, 1985). The total histamine
content was calculated as that measured in an aliquot of boiled cells.
Histamine release was expressed as a percentage of the total cellular
histamine content corrected for spontaneous release (i.e., that occurring
in the absence of any stimulus).
Sensory neuropeptide depletion in rats and mice Neonatal rats
were pretreated on the second day of life with a single subcutaneous
injection of 50 mg per kg capsaicin. This treatment has been shown to
permanently destroy the majority of sensory nerve ®bres (Lembeck and
Holzer, 1979) allowing the assessment of the role of sensory ®bres in
sensory-mediated physiologic responses. Blisters were induced and
peptides perfused in these rats at the age of 3 mo. Ef®cacy of this
treatment was con®rmed as previously described (Khalil et al, 1994;
Khalil, 1999).
Mice were depleted of sensory neuropeptides as previously described
(Garssen et al, 1998). When mice were 4 wk of age, they were
anesthetized (ketamine 75 mg per kg and medetomidine 1 mg per kg
intraperitoneally) and injected subcutaneously (50 ml) in the neck region
with capsaicin (25 mg per kg; Sigma) or vehicle control (alcohol:Tween-
80:saline, 2:1:7) on two consecutive days. Mice were not UV irradiated
or administered UCA until they were 8±9 wk of age. After completion
of the CHS assays, sensory neuropeptide depletion was con®rmed as
previously described (Garssen et al, 1998).
Blister induction and peptide perfusion A blister of 0.25 cm2 was
induced on the hind footpad of the anesthetized rat by applying a
vacuum pressure of ±40 kPa to the glabrous skin for approximately
30 min, using a metal suction cap heated to 40°C by an attached heating
element (Khalil et al, 1994; Khalil, 1999). This induction period lasted
30 min in both control and capsaicin-pretreated rats. When a blister was
established, the surface epithelium was removed and a Perspex chamber
with inlet and outlet ports was ®xed over the blister base. Perfusion of
the drugs over the blister was maintained at 4 ml per h by a peristaltic
pump (Microperpex S, LKB, Sweden). Both perfusion temperature and
body temperature were kept at 37°C. The experimental protocol
consisted of an initial 20 min equilibration with Ringer's solution to
establish a stable baseline. Sodium nitroprusside, a direct smooth muscle
vasodilator, was perfused at 100 mM for 10 min. The latter is used to
control for the variability in smooth muscle reactivity between rats. This
was followed by perfusion of Ringer's solution to re-stabilize the
baseline. trans-UCA or cis-UCA at different concentrations in Ringer's
solution was then perfused for 20 min. Finally there was a 10 min post-
stimulation period with perfusion of Ringer's solution followed by a
second perfusion of sodium nitroprusside to test for the indirect effect of
UCA on smooth muscle reactivity. In some experiments, the substance P
receptor antagonist RP-67580 (10 mM, gift of Rhone Poulenc Rorer
Chemicals, France) and the CGRP receptor antagonist CGRP8±37
(10 mM, Sigma) were perfused for 10 min prior to, and concomitant
with, perfusion of cis-UCA or trans-UCA.
Measurement of cutaneous blood ¯ow A laser Doppler ¯owmeter
probe (Peri¯ux, PF2B, Perimed, Sweden) was positioned vertically over
the exposed blister in the hindpaw via the Perspex chamber. The ¯ux
output of the laser Doppler monitor is a function of the concentration
and the velocity of the red blood cells moving in the tissue penetrated
by the laser light. The changes in relative blood ¯ow (as determined by
changes in red cell ¯ux) were continuously displayed on a chart recorder.
Raw data were evaluated by calculating the area under the response
curve (cm2). All measurements were made relative to a stable baseline
obtained prior to drug perfusion. The baselines did not differ between
control and capsaicin-pretreated rats or control and any other acute
treatment groups.
Assay of CHS Five days after UV irradiation or UCA administration,
mice (generally ®ve per group) were sensitized on the shaved ventral
skin with 100 ml freshly prepared 5% (wt/vol) TNCB (Tokyo Kasei
Kogyo, Tokyo, Japan) in acetone. Five days later and after coding the
identities of the mouse groups, a CHS response was elicited by applying
10 ml freshly prepared 1% TNCB in acetone to each of the ventral and
dorsal surfaces of both ears. Twenty-four hours after challenge, the ear
thickness was measured with a micrometer (Mitutoyo, Tokyo, Japan)
and the extent of ear swelling for each mouse was calculated by
subtracting the ear thickness before challenge. From this value was
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subtracted the mean swelling measured in mice that were challenged, but
not sensitized, with TNCB (approximately 0.03 mm).
Expression of data and statistical analysis Vasodilator responses
were measured as the area under the response curve (cm2) using a digital
planimeter (Tamaya, Japan). Results are expressed as mean 6 SEM.
Statistical analyses were performed using one-way analysis of variance
followed by a Student±Newman±Keuls post hoc test. SNP responses were
used as a covariate in the analysis. For measurements of histamine release
from mast cells, the mean results from each of multiple experiments were
used to calculate the mean value 6 SEM. In the CHS assays, a multiple
comparison procedure using a one-way analysis of variance and Fisher's
least signi®cance difference test was used to determine the statistical
signi®cance. Signi®cance was set at p < 0.05.
RESULTS
cis-UCA does not degranulate rat peritoneal mast
cells Neither cis- nor trans-UCA (700 mM) signi®cantly
increased histamine release from rat peritoneal mast cells
(Table I). Lower concentrations of UCA (7±70 mM) were also
ineffective (data not shown). In contrast, the neuropeptides
substance P and CGRP both stimulated histamine release
(Table I). Increasing concentrations of 48/80 were tested as a
positive mast cell degranulant.
cis-UCA increases microvascular blood ¯ow cis-UCA dose
dependently increased microvascular blood ¯ow in a rat hind
paw blister base (Fig 1A). The area under the response curve
reached 12.8 6 1.2 cm2 and 26.2 6 4.0 cm2 in response to 1 and
10 mM perfusion, respectively. trans-UCA was tested at both 1 and
10 mM but was without effect (Fig 1B). To determine if trans-
UCA (10 mM) competed with cis-UCA (10 mM) for receptor
occupancy, trans-UCA was perfused simultaneously with cis-UCA
over the blister base but no antagonistic effect was observed
(Fig 1B).
cis-UCA effects on microvascular ¯ow due to neuropeptide
release To investigate the mechanism by which cis-UCA
increased microvascular ¯ow, the blister base was perfused with
RP-67580 and CGRP8±37, each at 10 mM, prior to cis-UCA. RP-
67580 signi®cantly inhibited the vascular response by 56% with
the area under the response curve reaching 11.2 6 0.9 cm2.
CGRP8±37, on the other hand, reduced the response by 32% to
17.8 6 2.4 cm2. This reduction, however, did not reach statistical
signi®cance. Figure 2 also demonstrates that substance P and
CGRP were responsible in a cumulative fashion for 76% of the
effect seen in response to cis-UCA. The vascular response to
cis-UCA in the presence of the combined antagonists
(6.2 6 1.4 cm2) was signi®cantly different from the control
response as well as from the response in the presence of the
substance P antagonist alone, indicating a signi®cant contribution of
CGRP.
cis-UCA has residual effect on microvascular blood ¯ow in
sensory-neuropeptide-depleted rats To con®rm that the
effect of cis-UCA on microvascular ¯ow was due, in large part, to
its effects on sensory nerves, rats were depleted of sensory
neuropeptides with capsaicin early in life. As shown in Fig 3,
even in the sensory-neuropeptide-depleted rats, cis-UCA had a
small stimulatory effect on microvascular ¯ow that was not reduced
by antagonists to substance P or CGRP, tested in isolation or
together. Thus, cis-UCA has a small direct microvascular effect.
cis-UCA, like UVB, does not suppress systemic CHS
responses in sensory-neuropeptide-depleted mice To
determine the importance of cis-UCA on sensory nerves for
neuropeptide release to suppression of systemic CHS responses by
UVB and cis-UCA in rodents, the immunomodulatory effects of
UVB (8 kJ per m2) and cis-UCA (200 mg per mouse
subcutaneously) on CHS responses were examined in capsaicin-
treated BALB/c mice. As previously published by Garssen and
coworkers for UVB suppression of CHS responses in mice (Garssen
et al, 1998), the immunomodulatory effects of UVB and cis-UCA as
detected in control mice were not detected in the capsaicin-
pretreated mice (Fig 4).
DISCUSSION
Our previous studies demonstrated that both cis-UCA and dermal
mast cells by their release of histamine were critical to the ability of
UVB to suppress ``systemic'' CHS responses in mice (Hart et al,
1997, 1998a,b, 1999). cis-UCA could not directly degranulate
peritoneal mast cells, however, which are connective tissue mast
cells like those in skin. In contrast, both substance P and CGRP
dose-dependently stimulated histamine release. cis-UCA was also
unable to stimulate histamine release from less mature, bone-
marrow-derived mast cells (data not shown). As mast cells are
located adjacent to nerves in skin (Egan et al, 1998), we investigated
Table I. cis-UCA does not degranulate rat peritoneal mast
cells
Mediator n
% histamine releasea
(mean + SEM)b
trans-UCA 700 mM 21 1 + 2
cis-UCA 700 mm 26 1 + 1
substance P 1 mm 8 3 + 2
substance P 10 mm 8 5 + 2
substance P 100 mm 8 30 + 8c
CGRP 0.1 mM 3 1 + 1
CGRP 2.0 mM 3 1 + 1
CGRP 25 mM 3 7 + 1
CGRP 50 mM 3 30 + 1c
48/80 1 mg per ml 16 35 + 7c
48/80 5 mg per ml 16 45 + 7c
48/80 10 mg per ml 16 57 + 7c
aHistamine release has been expressed as a percentage of the total cellular hista-
mine content corrected for spontaneous release.
bThe mean value for replicates from each of n experiments has been used to cal-
culate the mean + SEM for n experiments.
cp < 0.05.
Figure 1. The effect of cis-UCA on microvascular blood ¯ow.
(A) Dose-dependent increase in microvascular blood ¯ow in response to
cis-UCA perfused for 20 min over the base of a blister raised on the hind
footpad of naõÈve rats. cis-UCA was perfused at concentrations of
100 mM, 1 mM, and 10 mM for six to eight rats per group. An asterisk
denotes signi®cantly different from cis-UCA at 1 mM. (B) The effect of
trans-UCA and cis-UCA (each at 10 mM) perfused for 20 min in
isolation or together on microvascular blood ¯ow recorded from the base
of blisters raised on the hind footpad of naõÈve rats. For six to eight rats
per group, trans-UCA did not induce a change in baseline blood ¯ow.
cis-UCA alone induced an increase in microvascular blood ¯ow that was
not signi®cantly different from the response obtained to combined
perfusion of both cis-UCA and trans-UCA.
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whether cis-UCA could indirectly stimulate mast cell degranulation
by activating sensory nerves for neuropeptide release. A well-
documented read-out system was adopted that allowed the
dissection of neuropeptide-dependent changes in microvascular
¯ow over a rat hind-paw blister base (Khalil et al, 1994; Khalil,
1999). cis-UCA, but not trans-UCA, increased microvascular ¯ow
in a predominantly substance P- and CGRP-dependent manner.
This is the ®rst report of a functional effect of cis-UCA on the
peripheral terminals of primary afferent sensory nerves. That
neuropeptides were important in cis-UCA-induced immunomo-
dulation was con®rmed in sensory-neuropeptide-depleted mice.
cis-UCA and g-amino-butyric acid (GABA) are analogs and it was
reported that cis-UCA bound competitively to GABA receptors in
rat cortex membranes (Laihia et al, 1998). The functional relevance
of this binding was challenged, however, because GABA receptors
are not generally found on peripheral nerves. GABA (10 mM) did
not alter microvascular ¯ow in our blister model (data not shown).
In this study, cis-UCA stimulated neuropeptide release, which
linked cis-UCA with control of mast cell degranulation. The
contribution of microvascular changes induced by cis-UCA to UV-
induced immunomodulation remains unknown. It has been
published that sensory nerves in the skin terminate near
Langerhans cells in the epidermis (Hosoi et al, 1993) and are
therefore close to the site of cis-UCA formation and in the diffusion
path of the more soluble UCA isomer. Dermal mast cells are
generally located in skin near nerves and blood vessels. Thus, a
functional link between cis-UCA, sensory nerves, mast cells, and, in
our blister model, blood vessels, is anatomically defensible.
Our conclusions contrast with those of Wille and colleagues who
used human skin organ cultures (Wille et al, 1999). It has been
shown that, although the axons of sensory nerves are cut in the
preparation of small skin explants, the nerve endings seal up at the
point of severance and remain susceptible for at least 24 h to
activation in vitro (Kilo et al, 1997). We hypothesize that in the skin
organ cultures cis-UCA was activating dermal mast cells indirectly
via its effect on the sensory nerves. The microvascular changes
detected could not have been due to cis-UCA degranulating mast
cells directly. Perfusion of the mast cell product, histamine, at
100 mM was without effect on cutaneous blood ¯ow (data not
shown). At 100 mM, however, histamine could potentiate the
vascular response to substance P (data not shown).
A role for neuropeptides in UVB-induced ``systemic'' immu-
nosuppression was ®rst proposed by Garssen et al (1998). CGRP
had been previously implicated in stimulating degranulation of mast
cells in UV-irradiated skin (Niizeki et al, 1997; Alard et al, 1999).
Streilein and colleagues previously reported that mast cell
degranulation was critical for UV-induced ``local'' immunosup-
pression in mice (hapten applied within 30 min to the irradiated
site) and that this effect was reduced by intradermal administration
of a CGRP receptor antagonist (Niizeki et al, 1997). By use of
Figure 3. The effect of substance P and CGRP receptor
antagonists (RP-67580 and CGRP8±37, respectively, each at
10 mM) on the vascular response to cis-UCA (10 mM) in sensory-
neuropeptide-depleted rats. For six to eight rats per group, vascular
responses were recorded from the base of blisters raised on the hind
footpads of capsaicin-pretreated rats. The receptor antagonists (alone or
in combination) were perfused for 10 min prior to and concomitant
with cis-UCA. No signi®cant differences were observed between groups.
Figure 2. The effect of receptor antagonists to substance P and
CGRP (RP-67580 and CGRP8±37, respectively, each at 10 mM) on
the vascular response to cis-UCA (10 mM). For six to eight rats per
group, vascular responses were recorded from the base of blisters raised
on the hind footpads of naõÈve rats. The antagonists (alone or in
combination) were perfused for 10 min prior to and concomitant with
cis-UCA. An asterisk denotes a signi®cant difference from cis-UCA
(10 mM). A cross denotes a signi®cant difference from cis-UCA
(10 mM) in the presence of RP-67580 alone.
Figure 4. The effect of UVB and cis-UCA on the CHS responses
of sensory-neuropeptide-depleted and control BALB/c mice to
the hapten, TNCB. Four-week-old mice were injected subcutaneously
in the neck region with capsaicin (25 mg per kg) on two consecutive
days. After a further 4 wk, in (A) mice were untreated or irradiated with
8 kJ per m2 UVB. In (B) mice were injected subcutaneously on their
backs with cis-UCA (200 mg per mouse) or, as a control, trans-UCA
(200 mg per mouse). The mean change in ear swelling (+ SEM) for ®ve
mice per group is shown; the groups of mice were always coded before
challenge with hapten and ear thickness measurements. An asterisk
denotes a result signi®cantly different (p < 0.05) from that of
nonirradiated mice in (A) or mice treated with trans-UCA in (B).
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CGRP and substance P receptor antagonists administered system-
ically, Garssen and coworkers also found a role for CGRP, but not
substance P, in UVB-induced systemic immunosuppression
(Garssen et al, 1998). Garssen and colleagues used RP-67580, the
same substance P receptor antagonist that was used in this study, to
inhibit substance P binding to its receptor on sensory nerves. We
hypothesize that substance P was not implicated in that study
because substance P does not act on mast cells by a receptor-
dependent mechanism (which RP-67580 will affect) but by a
unique pertussis toxin-sensitive, cation-dependent, receptor-inde-
pendent process (Mousli et al, 1989; Cocchiara et al, 1999). These
previous studies did not implicate cis-UCA in these neuropeptide-
dependent effects of UVB. Attempts to cause an immunosuppres-
sion by administration of CGRP and substance P 5 d prior to
hapten sensitization were unsuccessful (data not shown), presum-
ably because of the short half-life of the neuropeptides.
Although a well-known mast cell degranulating agent, substance
P has not been previously recognized as an immunosuppressive
molecule. In fact, it is generally recognized to stimulate certain
parameters of the immune response (Ansel et al, 1996) and a
substance P agonist administered within 30 min of the sensitizing
antigen could act as an adjuvant to promote hapten-speci®c skin
immunity (Niizeki et al, 1999). There is evidence that substance P
can cause immune enhancement or immune suppression depending
on the other factors involved (Khalil, 1999; Khalil et al, 2000).
The concentration of cis-UCA required for neuropeptide release
was 1 mM, i.e., 184 mg during the 20 min perfusion of 1.3 ml. If
cis-UCA acts by a receptor-driven system, this may appear high
particularly as the concentration of UCA in rat dorsal or ear skin is
4±8 mg per cm2 (Garssen et al, 1999). Due to the extravascular
route of administration used in this study, however, a 100-fold
higher concentration than would be required if administered
intravascularly was required to overcome the diffusion barrier. A
concentration of 1 mM cis-UCA was previously found to block
50% of speci®c binding of GABA to rat cortex membranes whereas
1 mM trans-UCA inhibited 23% of binding of GABA to its
receptor (Laihia et al, 1998). In our studies of cis-UCA on
monocyte activity, cis-UCA was active at a similar range of
concentrations, i.e., cis-UCA at concentrations greater than or
equal to 0.1 mM (Hart et al, 1993). For human skin, a concen-
tration of UCA of 0.3±8.9 mM within the estimated 70 mm thick
epidermis has been calculated (Bruls et al, 1984; Laihia et al, 1998),
of which 50% would be cis-UCA after UVB irradiation. In human
skin organ cultures (Wille et al, 1999), a concentration of cis-UCA
of 75 mg per ml (0.5 mM) was required for maximal induction of
E-selectin on microvessels by a pathway attributed to mast-cell-
derived tumor necrosis factor a.
There have been several reports that CGRP can downregulate
the activity of Langerhans cells, the antigen-presenting cells of
epidermal skin (Hosoi et al, 1993; Lambert and Granstein, 1998).
Activation of the CGRP receptor on Langerhans cells increases
production of cAMP by adenylate cyclase and augmentation of
lipopolysaccharide- and granulocyte±macrophage colony stimulat-
ing factor-induced interleukin 10 (IL-10) production (Asahina et al,
1995). IL-10 downregulates B7-2 and inhibits antigen presentation
by Langerhans cells (Lambert and Granstein, 1998). In models of
local UVB-induced immunomodulation, cis-UCA-induced pro-
duction of CGRP may be important in regulation of Langerhans
cell activity. cis-UCA-induced neuropeptides may also regulate
other cells of irradiated skin, including keratinocytes. Substance P
can bind normal human keratinocytes and stimulate IL-1 secretion
(Kemeny et al, 1994; Lambert and Granstein, 1998).
In summary, this study has identi®ed unmyelinated capsaicin-
sensitive sensory nerves as an important responder cell to cis-UCA
produced by UV isomerization of trans-UCA. In turn, neuropep-
tides are released that may activate neighboring mast cells. These cis-
UCA-induced neuropeptides may also play an important role in
regulation of other immune and in¯ammatory cells involved in
cutaneous in¯ammation following UV exposure.
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